构建和评估针对马尔堡病毒的基于糖蛋白的核酸疫苗

Xiyang Zhang1,2, Yubo Sun1, Jiaxing Zhang1

  • 1Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University), Xi'an, 710032, Shaanxi, China.

PubMed
概括

针对马尔堡病毒 (MARV) 的新型DNA和mRNA疫苗有望预防马尔堡出血热 (MHF). 这两种疫苗类型在小鼠中产生了强烈的免疫反应和中和抗体,这表明未来对MHF控制的潜力.